Daniel J. Brennan - 16 Feb 2023 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Role
EVP and CFO
Signature
/s/ Susan Thompson, Attorney-in-Fact
Issuer symbol
BSX
Transactions as of
16 Feb 2023
Net transactions value
-$229,228
Form type
4
Filing time
21 Feb 2023, 15:16:41 UTC
Previous filing
16 Feb 2023
Next filing
22 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BSX Common Stock Options Exercise $0 +4,243 +1.5% $0.000000 280,559 16 Feb 2023 Direct F1
transaction BSX Common Stock Tax liability $58,100 -1,250 -0.45% $46.48 279,309 16 Feb 2023 Direct
transaction BSX Common Stock Options Exercise $0 +4,583 +1.6% $0.000000 283,892 17 Feb 2023 Direct F1
transaction BSX Common Stock Tax liability $94,616 -2,033 -0.72% $46.54 281,859 17 Feb 2023 Direct
transaction BSX Common Stock Options Exercise $0 +3,706 +1.3% $0.000000 285,565 18 Feb 2023 Direct F2
transaction BSX Common Stock Tax liability $76,512 -1,644 -0.58% $46.54 283,921 18 Feb 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BSX Restricted Stock Units Options Exercise $0 -4,243 -25% $0.000000 12,729 16 Feb 2023 Common Stock 4,243 Direct F1, F3
transaction BSX Restricted Stock Units Options Exercise $0 -4,583 -33% $0.000000 9,167 17 Feb 2023 Common Stock 4,583 Direct F1, F4
transaction BSX Deferred Stock Units Options Exercise $0 -3,706 -50% $0.000000 3,706 18 Feb 2023 Common Stock 3,706 Direct F2, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F2 Each deferred stock unit represents the Company's commitment to issue on share of Boston Scientific common stock.
F3 Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 16, 2023, the first anniversary of the date of grant.
F4 Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 17, 2022, the first anniversary of the date of grant.
F5 Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 18, 2021, the first anniversary of the date of grant.